ProQR Therapeutics (PRQR) Shares Outstanding (Diluted Average) (2022 - 2025)
ProQR Therapeutics (PRQR) has disclosed Shares Outstanding (Diluted Average) for 4 consecutive years, with $122.6 million as the latest value for Q4 2025.
- Quarterly Shares Outstanding (Diluted Average) rose 33.29% to $122.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $122.6 million through Dec 2025, up 33.29% year-over-year, with the annual reading at $122.6 million for FY2025, 33.29% up from the prior year.
- Shares Outstanding (Diluted Average) hit $122.6 million in Q4 2025 for ProQR Therapeutics, up from $92.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $122.6 million in Q4 2025 to a low of $73.1 million in Q4 2022.
- Historically, Shares Outstanding (Diluted Average) has averaged $93.7 million across 4 years, with a median of $89.6 million in 2023.
- Biggest five-year swings in Shares Outstanding (Diluted Average): grew 5.54% in 2024 and later surged 33.29% in 2025.
- Year by year, Shares Outstanding (Diluted Average) stood at $73.1 million in 2022, then rose by 19.25% to $87.2 million in 2023, then increased by 5.54% to $92.0 million in 2024, then skyrocketed by 33.29% to $122.6 million in 2025.
- Business Quant data shows Shares Outstanding (Diluted Average) for PRQR at $122.6 million in Q4 2025, $92.0 million in Q4 2024, and $87.2 million in Q4 2023.